We demonstrate here that challenging DR4xRIP-B7.1 mice with overlapping peptides derived from murine proinsulin-2 in adjuvant induces type 1 diabetes in the majority of animals within 20 weeks post-prime and that this disease reflects the human condition. Here, CD80 is linked to type 1 diabetes mellitus.